Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (2)
  • IGF-1R
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

insulin(cattle)

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
Insulin(cattle)
Insulin from bovine pancreas
TP112511070-73-8
Insulin(cattle) is a peptide hormone that promotes glycogen synthesis and regulates glucose levels in the blood. Insulin has hypoglycemic activity and is used clinically to treat hyperglycemia in diabetic patients.
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
C16 Lactosylceramide (d18:1/16:0)
T358044201-62-1
C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle. C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder.
  • $1,187
Inquiry
Size
QTY
C18:1 Ceramide (d18:1/18:1(9Z))
Cer(d18:1/18:1(9Z)), C18:1-Ceramide
T358085966-28-9
C18:1 Ceramide (d18:1/18:1(9Z)) is a ceramide, and C18:1-Ceramide levels are elevated in overweight and insulin-resistant mice and cattle, as well as in plasma and ovarian tissue of patients with advanced ovarian cancer.
  • $35
In Stock
Size
QTY
C18:1 Ceramide (d18:1/18:1(9Z)) (Standard)
TMSM-31885966-28-9
C18:1 Ceramide (d18:1/18:1(9Z)) (Standard) is a reference standard for research and analysis in studies involving C18:1 Ceramide (d18:1/18:1(9Z)). C18:1 Ceramide (d18:1/18:1(9Z)) is a ceramide, and C18:1-Ceramide levels are elevated in overweight and insulin-resistant mice and cattle, as well as in plasma and ovarian tissue of patients with advanced ovarian cancer.
  • $1,680
4-6 weeks
Size
QTY